On Monday, ATAI Life Sciences N.V (NASDAQ: ATAI) opened higher 9.29% from the last session, before settling in for the closing price of $3.23. Price fluctuations for ATAI have ranged from $1.03 to $3.35 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 18.62%. Company’s average yearly earnings per share was noted 50.00% at the time writing. With a float of $137.08 million, this company’s outstanding shares have now reached $199.78 million.
Considering the fact that the conglomerate employs 54 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 87.92%, operating margin of -5312.18%, and the pretax margin is -8014.28%.
ATAI Life Sciences N.V (ATAI) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of ATAI Life Sciences N.V is 31.72%, while institutional ownership is 10.05%. The most recent insider transaction that took place on Jul 02 ’25, was worth 233,830. Before that another transaction happened on Jul 01 ’25, when Company’s Officer proposed sale 106,093 for $2.77, making the entire transaction worth $294,381.
ATAI Life Sciences N.V (ATAI) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 50.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.93% during the next five years compared to 18.62% growth over the previous five years of trading.
ATAI Life Sciences N.V (NASDAQ: ATAI) Trading Performance Indicators
Check out the current performance indicators for ATAI Life Sciences N.V (ATAI). In the past quarter, the stock posted a quick ratio of 4.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2147.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.50 in one year’s time.
Technical Analysis of ATAI Life Sciences N.V (ATAI)
Compared to the last year’s volume of 3.22 million, its volume of 7.21 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 78.66%.
During the past 100 days, ATAI Life Sciences N.V’s (ATAI) raw stochastic average was set at 97.14%, which indicates a significant increase from 94.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.25 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.28, while its 200-day Moving Average is $1.68.
